One such blocking factor in CTCL could be TGFβ (18), which is known to inhibit the induction of granzyme B, IFNγ and perforin and the release of cytotoxic granules (42). The gene discussed is PRF1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.